Malignant Neuroendocrine Carcinoma clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
Pembrolizumab-based Therapy in Previously Treated High Grade Neuroendocrine Carcinomas
Sorry, in progress, not accepting new patients
This is a pilot study of pembrolizumab-based therapy in previously treated extrapulmonary poorly differentiated neuroendocrine carcinoma
San Francisco, California and other locations
Our lead scientists for Malignant Neuroendocrine Carcinoma research studies include Emily Bergsland, MD.
Last updated: